Patients with acute respiratory distress syndrome (ARDS) second to COVID-19 improved with early continuous positive airway pressure (CPAP) and high-flow nasal cannula (HFNC) treatment, a study finds.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results